BioSpace News Archive

Gibraltar Industries, Inc. (Nasdaq: ROCK), a leading manufacturer and provider of products and services for the renewable energy, residential, agtech and infrastructure markets, today announced that Chairman and Chief Executive Officer Bill Bosway and Chief Financial Officer Tim Murphy are scheduled to present at the CJS 22nd Annual New Ideas Summer Conference on Tuesday, July 12, 2022.

The global market for cell culture protein surface coatings is slated to expand at a highly promising pace in the next few years, thanks to the vast rise in investments by governments and market players in stem cell research and development activities.

Wilmington, Delaware, United States, Transparency Market Research Inc.: Wound closure devices help in efficient healing of wounds in accordance with the specific type of tissue, needs, and function.

Wilmington, Delaware, United States, Transparency Market Research Inc.: Ulcerative colitis is an inflammatory bowel disease that involves the chronic inflammation of the colon or large intestine.

Wilmington, Delaware, United States, Transparency Market Research Inc.: The global medical dynamometer market is driven by increase in the number of surgeries and rise in prevalence of bone injuries.

On July 7, 2022, invoX Pharma Limited (“invoX”) , a wholly owned subsidiary of Sino Biopharmaceutical Limited (“Sino Biopharm”) (HKEX 1177 HK) commenced a cash tender offer for all of the issued and outstanding shares of common stock of F-star Therapeutics, Inc. (“F-star”) (NASDAQ:FSTX) for a price of $7.12 per share.

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines, today announced the appointment of Leigh Morgan to its Board of Directors.

New smart sensors, which assist in the soft tissue balancing and correct positioning of an orthopaedic implant during hip replacement, are expected to prolong implant lifetimes and reduce the chances of patients needing difficult revision surgery.